23340-69-4 Usage
Uses
Used in Organic Synthesis:
5-Cyano-dimethylisophthalate is utilized as a building block in organic synthesis for the creation of various chemical compounds. Its unique structure allows it to be a key component in the synthesis of complex organic molecules.
Used in Pharmaceutical Production:
In the pharmaceutical industry, 5-Cyano-dimethylisophthalate is used as a precursor in the production of various pharmaceuticals and fine chemicals. Its versatility in chemical reactions makes it valuable for the development of new drugs and medicinal compounds.
Used in Metalworking Fluids:
5-Cyano-dimethylisophthalate is employed as a corrosion inhibitor in metalworking fluids. Its ability to prevent the corrosion of metal surfaces during manufacturing processes contributes to the longevity and performance of metal components.
Used in Polymer Stabilization:
In the plastics industry, 5-Cyano-dimethylisophthalate serves as a stabilizer in PVC and other polymers. It helps to prevent the degradation of polymers, thereby enhancing their durability and resistance to environmental factors.
Check Digit Verification of cas no
The CAS Registry Mumber 23340-69-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,3,4 and 0 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 23340-69:
(7*2)+(6*3)+(5*3)+(4*4)+(3*0)+(2*6)+(1*9)=84
84 % 10 = 4
So 23340-69-4 is a valid CAS Registry Number.
23340-69-4Relevant academic research and scientific papers
AMIDE DERIVATIVES AS INHIBITORS OF ASPARTYL PROTEASES
-
Page/Page column 72, (2008/12/04)
The invention provides compounds of the formula (I). N-oxides, addition salts, quaternary amines, metal complexes, stereochemically isomeric forms and metabolites thereof, wherein W is H, C1-C6alkyl, C3-C6cycloalkyl, aryl or heterocyclyl; Q is aryl or heterocyclyl; A is a five or six membered saturated, partially unsaturated or aromatic ring; D is formula (II) or formula (III); and the other variables are as defined in the specification. The compounds of the invention are inhibitors of aspartyl proteases such as renin and BACE and are among other things useful for the treatment and/or prophylaxis of conditions associated with activities of the RAS, such as hypertension, heart failure and renal insufficiency and for the treatment and or prophylaxis of conditions associated with BACE activity such as of Alzheimer's disease.
